BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

Plant Biotechnology Journal, published by Wiley, is a premier open-access platform dedicated to advancing the field of plant biotechnology. Since its inception in 2003, this journal has played a pivotal role in disseminating high-quality research that enhances our understanding of plant genomics, biochemistry, and molecular biology. With an impressive impact factor and a prominent position in Q1 quartiles across Agronomy, Crop Science, Biotechnology, and Plant Science, it ranks among the top journals globally, reflecting its significant influence in the agricultural and biological sciences. Researchers and professionals can access cutting-edge studies and reviews that facilitate innovation in sustainable crop production and biotechnology applications. The journal's transition to an open access model since 2016 has further amplified its reach, ensuring that vital research is available to a global audience, promoting collaboration and knowledge sharing within the scientific community.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, published by Wiley, is a renowned journal that bridges the gap between fundamental research and practical applications in the fields of biochemistry and biotechnology. With an ISSN of 0885-4513 and an E-ISSN of 1470-8744, this journal has been instrumental since its inception in 1986, focusing on diverse topics including applied microbiology, drug discovery, and process chemistry. The journal is currently recognized in various categories with impressive quartile rankings, showcasing its influence with placements in Q2 for applied microbiology, biotechnology, and biomedical engineering, among others. Researchers and professionals benefit from its comprehensive scope and critical insights into the latest advancements in these domains. Although not an open-access journal, it provides invaluable access options for academic institutions and professionals seeking to stay at the forefront of biotechnology innovations. Its commitment to presenting quality research facilitates the growth of knowledge and fosters collaborations across disciplines, making it an essential resource for anyone invested in the rapidly evolving landscape of biosciences.

BIOSYSTEMS ENGINEERING, published by Academic Press Inc. Elsevier Science, is a leading journal that has established itself as a key contributor in the fields of agronomy, crop science, animal science, food science, soil science, and control systems engineering. With an impressive position in the 2023 Category Quartiles, featuring Q1 rankings in Agronomy and Crop Science, Animal Science and Zoology, Food Science, and Soil Science, alongside a Q2 ranking in Control and Systems Engineering, this journal stands at the forefront of innovative research. Currently indexed in Scopus, it boasts a commendable track record, with its Agricultural and Biological Sciences rankings placing it in the 95th percentile for Agronomy and Crop Science and the 90th percentile for Soil Science, among others. With a commitment to disseminating critical advancements and fostering scientific dialogue, BIOSYSTEMS ENGINEERING offers an invaluable platform for researchers, professionals, and students alike, seeking to advance their understanding and application of engineering principles in biological systems. As a hybrid journal that provides both subscription and open access options, it ensures broad accessibility to high-quality research that shapes the future of sustainable agriculture and biological systems.

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

Plant Biotechnology is a distinguished journal published by the Japanese Society for Plant Cell and Molecular Biology, committed to advancing the field of plant biotechnology through the dissemination of high-quality research. With an ISSN of 1342-4580, this journal caters to a global audience interested in agronomy, crop science, and plant molecular biology. The journal has achieved notable rankings, including Q2 in Agronomy and Crop Science and Q2 in Plant Science, underscoring its relevance and impact in these fields according to the latest 2023 metrics. Furthermore, it holds a respectable position within Scopus rankings across multiple categories, indicating its contribution to the academic community. Although it is not an open-access journal, its regular publications, spanning from 1997 to 2024, feature cutting-edge studies that explore innovative approaches and technologies in plant science. Researchers, professionals, and students will find Plant Biotechnology an essential resource for staying informed on significant advancements and trends in plant research.

BIOTECHNOLOGY PROGRESS, a prominent journal published by Wiley, stands at the forefront of the biotechnology field, delivering cutting-edge research and emerging trends since its inception in 1985. With an ISSN of 8756-7938 and an E-ISSN of 1520-6033, this journal has carved out a significant niche within the academic community, reflected in its Q2 ranking within the Biotechnology category for 2023. Maintaining a strong presence in the Scopus database, it ranks #111 out of 311 in the categories of Biochemistry, Genetics, and Molecular Biology, demonstrating its commitment to quality and significance in the field. Although it does not offer open access, it remains accessible through various institutional subscriptions, ensuring that vital biological and biotechnological discoveries reach a broad audience, including researchers, professionals, and students. Given its rigorous peer-review process and a focus on innovative methodologies, BIOTECHNOLOGY PROGRESS is an indispensable resource for anyone looking to stay informed about the latest advancements and applications in biotechnology.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

Marine Biotechnology is a premier journal published by Springer, specializing in the interdisciplinary research at the intersection of marine biology and biotechnology. With an ISSN of 1436-2228 and a robust e-ISSN of 1436-2236, this journal has been a cornerstone for scholars and practitioners since its inception in 1999, and is positioned to continue shaping the field through 2024. Recognized for its contributions in Aquatic Science and Biotechnology, it currently holds a Q2 ranking in both categories for 2023, highlighting its relevance and impact within the global scientific community. With a Scopus rank of 64/247 in Aquatic Science and 149/311 in Biotechnology, Marine Biotechnology offers a vital platform for disseminating cutting-edge research that encompasses environmental sustainability, pharmaceutical applications, and bioinformatics. The journal promotes open access to its valuable content, ensuring that research is readily available to a wide audience. By bringing together leading researchers and fostering collaborations, Marine Biotechnology stands as an essential resource for those committed to advancing our understanding of marine resources and their applications in biotechnology.